PMC:7696151 / 1910-2249
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 58 | 24-31 | Chemical | denotes | quinine | MESH:D011803 |
| 59 | 260-271 | Chemical | denotes | chloroquine | MESH:D002738 |
| 60 | 273-275 | Chemical | denotes | CQ | MESH:D002738 |
| 61 | 40-47 | Disease | denotes | malaria | MESH:D008288 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T18 | 0-131 | Sentence | denotes | The increasing need for quinine, due to malaria diffusion, led the pharmaceutical industry to the creation of a synthetic molecule. |
| T19 | 132-195 | Sentence | denotes | In 1934 Johann (Hans) Andersag and co-workers at the Bayer I.G. |
| T20 | 196-339 | Sentence | denotes | Farbenindustrie in Elberfeld laboratories, Germany, synthesized chloroquine (CQ) for the first time, judged by the Germans to be too toxic [4]. |